Education
About Us
Working with TipRanks
Follow Us
Elixxer (ELIXF)
OTHER OTC:ELIXF
ELIXF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.06 - $0.06
Previous CloseN/A
Volume2.80K
Average Volume (3M)3.33K
Market Cap
$696.57K
Enterprise Value$25.62M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.56
Next Earnings
Nov 20, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding11,338,887
10 Day Avg. Volume3,327
30 Day Avg. Volume3,327
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap36.78
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Elixxer News
ELIXF FAQ
What was Elixxer’s price range in the past 12 months?
Elixxer lowest stock price was $0.06 and its highest was $0.06 in the past 12 months.
What is Elixxer’s market cap?
Elixxer’s market cap is $696.57K.
When is Elixxer’s upcoming earnings report date?
Elixxer’s upcoming earnings report date is Nov 20, 2025 which is in 73 days.
How were Elixxer’s earnings last quarter?
Elixxer released its earnings results on Aug 29, 2025. The company reported -$0.04 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.04.
Is Elixxer overvalued?
According to Wall Street analysts Elixxer’s price is currently Overvalued.
Does Elixxer pay dividends?
Elixxer does not currently pay dividends.
What is Elixxer’s EPS estimate?
Elixxer’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Elixxer have?
Elixxer has 11,338,887 shares outstanding.
What happened to Elixxer’s price movement after its last earnings report?
Elixxer reported an EPS of -$0.04 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Elixxer?
Currently, no hedge funds are holding shares in ELIXF
Company Description
Elixxer
Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. It invests in cannabis-related businesses, which are fully licensed for cultivation, production, and/or sale of medical and specialty cannabis and cannabis-derived products in the pharmaceutical sector. The company was formerly known as LGC Capital Ltd. and changed its name to Elixxer Ltd. in August 2019. Elixxer Ltd. was incorporated in 2004 and is based in Montreal, Canada.
Mountain Valley MD
―
Khiron Life Sciences
―
Avant Brands
―
Nextleaf Solutions
―
Christina Lake Cannabis
―